Latest Cancer News

Xermelo-new option for controlling symptoms of Carcinoid Syndrome (03-1-2017)

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea. Carcinoid syndrome is a cluster of symptoms that occurs in patients with advanced neuroendocrine tumors (NET) [...]

Dalantercept- Inlyta Shows Promise for Renal Cell Cancer (03-1-2017)

The combination of Inlyta (axitinib) and dalantercept, an activin receptor–like kinase 1 (ALK1) signaling inhibitor appears promising in the treatment of advanced renal cell carcinoma (RCC) according to the results of a recently published Phase I clinical trial.1 According to investigators, 25% of RCC patients responded to treatment with the [...]

Chemo-brain Among Women with Breast Cancer is Very Common (02-28-2017)

The largest study to date of a condition known as “chemo-brain” shows that women with breast cancer report it’s a substantial problem after chemotherapy for as long as six months after treatment, according to investigators at the Wilmot Cancer Institute. Scientists have known that cancer-related cognitive impairment, which includes problems [...]

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors (02-23-2017)

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here. Although neuroendocrine tumors [...]

Unique Gene Signature Predicts Potentially Lethal Prostate Cancers (02-23-2017)

Standard therapy for prostate cancer, the third-leading cause of cancer-related deaths in American men, is based on blocking androgens, the male sex hormones. However, for some men, prostate cancer recurs despite androgen-deprivation therapy. A team of scientists led by Irwin Gelman, PhD, Professor of Oncology in the Department of Cancer Genetics at [...]

Targeted radiotherapy for head and neck cancer could reduce the risk of dry mouth (02-22-2017)

A troublesome side effect of radiation therapy treatment of cancers involving the head and neck is dry mouth.  This occurs as a consequence of radiation damage to the salivary glands.  According to a new study, changing the intensity of radiotherapy to protect the salivary glands could help treat a rare [...]

Genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndrome (02-21-2017)

A single blood test and basic information about a patient’s medical status can indicate which patients with myelodysplastic syndrome (MDS) are likely to benefit from a stem cell transplant, and the intensity of pre-transplant chemotherapy and/or radiation therapy that is likely to produce the best results, according to new research [...]

Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated! (02-20-2017)

By Rachel Tompa / Fred Hutch News Service The most common sexually transmitted infection in the U.S. has a bit of a twist. It’s what’s known as a “subclinical infection” — those infected suffer no immediate consequences, but years later have vastly increased risks for at least six different types [...]

Proton beam therapy may improve outcomes for pancreatic cancer (02-17-2017)

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for select cancers of the esophagus, anus, rectum, pancreatic, or small intestine. This treatment approach is often associated with improved outcomes but [...]

FDA Approves Opdivo for Treatment of Bladder Cancer (02-16-2017)

The US Food and Drug Administration (FDA) today approved Opdivo, (nivolumab) for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed during a period of up to 1 year after first-line platinum-containing chemotherapy. Bladder cancer will be diagnosed in approximately 77,000 people in the [...]

Vaccine Shows Promising Results for Early-Stage Breast Cancer Patients (02-15-2017)

Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Doctors at Moffitt Cancer Center in Tampa Florida are working on a promising new vaccine that would help early-stage breast cancer patients who have HER2 [...]

Twice-daily radiation therapy reduces mortality from head and neck cancer (02-14-2017)

Treating head and neck cancer patients with a twice-daily radiation therapy schedule combined with chemotherapy could save more lives, according to new research presented at the European Cancer Congress 2017.1 Around 600,000 people are diagnosed with head and neck cancer worldwide each year. It can be difficult to treat because [...]

« Previous PageNext Page »